This report is the companion to Contract Manufacturing Service Agreements - Rising Manufacturing Opportunities Driven by Pharmaceutical Pipeline Expansion (July 2020). IT covers contract manufacturing agreements for COVID-19 vaccines and drugs worldwide, across a range of different services and manufacturing scales. It covers clinical and commercial contracts. As COVID-19 pharmaceuticals are being ordered in billions of doses by numerous governments, the number of contract service agreements secured serves as an indicator of a CMO's performance. This report is critical for establishing an understanding of the overall CMO industry as it responds to the challenges and opportunities of the pandemic.
Scope
- This 52-page report gives an important expert quantitative analysis of the contract manufacturing industry's response to the COVID-19 pandemic. Findings are based on the industry’s most comprehensive databases of the CMO industry (the publisher's Databases of Contract Service Providers, Drugs, and Deals).
- This analysis is primarily driven by the Deals Database, which is continuously updated and reveals manufacturing relationships for Pharma products and the types of services offered. The 23 figures and 6 tables throughout the report illustrate major points and trends. This report is required reading for:
- CMO executives who must have deep understanding of the COVID-19 vaccine and drug landscape -- both pipeline and marketed -- to make strategic planning and investment decisions.
- Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
- Investors that need a deeper understanding of the market to identify and value potential investment targets.
Reasons to Buy
- Overview of contract manufacturing agreements worldwide for COVID-19 pharmaceuticals and the levels of outsourcing associated with different services and drug type
- Detailed view of CDMO performance by contract manufacturing agreement and an assessment of their manufacturing scale
- Manufacturing agreements are assessed by different molecule types, service type, dose form, facility geography, sponsor company types, and CDMO types.
Table of Contents
1. Executive Summary2 Players
3 Trends
4 Industry Analysis
5 Value Chain: Contract Manufacturing Service Agreements
6 Appendix
7 Companies
8 About the Authors
List of Tables
Table 1: Top Trends in COVID-19 Contract Manufacturing
Table 2: Promising Pipeline Therapies
Table 3: Promising Pipeline Vaccines
Table 4: Marketed Therapies and Vaccines
Table 5: Further Reading
Table 6: CDMOs with COVID-19 Contract Manufacturing Agreements
List of Figures
Figure 1: Leaders and Disruptors: Top Players in Outsourcing COVID-19 Vaccine/Therapeutic Manufacturing
Figure 2: Pipeline Therapies in Development for COVID-19
Figure 3: Pipeline Vaccines in Development for COVID-19
Figure 4: Clinical Trials of COVID-19 Therapies and Vaccines
Figure 5: The Contract Manufacturing Value Chain
Figure 6: COVID-19 Vaccine and Therapy Contract Manufacturing Agreements
Figure 7: Contract Manufacturing Agreements for COVID-19 Vaccines and Therapies - Manufacturing Facility Geography
Figure 8: Contract Manufacturing Agreements for COVID-19 Vaccines and Therapies - Manufacturing Facility Country
Figure 9: Contract Manufacturing Agreements for COVID-19 Vaccines - Manufacturing Facility Geography
Figure 10: Contract Manufacturing Agreements for COVID-19 Therapies - Manufacturing Facility Geography
Figure 11: COVID-19 Contract Manufacturing Agreements by Molecule Type
Figure 12: Contract Manufacturing Agreements by Service Type
Figure 13: Contract Manufacturing Agreements by Dosage Form
Figure 14: Outsourcing by API/Dose/Packaging
Figure 15: Count of Services Per Contract
Figure 16: Contract Manufacturing Agreements - Scale of Services
Figure 17: Top CDMOs by COVID-19 Contract Service Agreements
Figure 18: CDMOs with COVID-19 Contract Manufacturing Agreements - by Market Cap
Figure 19: Market Cap Bands of CDMOs (Therapies vs. Vaccines)
Figure 20: Contract Manufacturing Agreements by Top Products/Sponsors
Figure 21: Vaccine Contract Volume, Gamaleya and AstraZeneca
Figure 22: Vaccine API Contract Manufacturing Facilities, Worldwide
Figure 23: Vaccine API Contract Manufacturing Facilities, US
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- ABF Pharmaceutical Services GmbH
- Abzena Ltd
- Adienne Pharma & Biotech SA
- Advanced BioScience Laboratories Inc
- Advent Srl
- AGC Biologics Inc
- Ajinomoto Bio-Pharma Services
- Akron Biotechnology LLC
- Aldevron LLC
- Allergopharma GmbH & Co KG
- Almac Group Ltd
- Amgen Inc
- Apeptico Forschung und Entwicklung GmbH
- Aragen Bioscience Inc
- Aspen Pharmacare Holdings Ltd
- AstraZeneca UK Ltd
- Attwill Medical Solutions
- Avid Bioservices Inc
- Avra Laboratories Pvt Ltd
- Bachem Holding AG
- Bajaj Healthcare Ltd
- Batavia Biosciences BV
- Bausch Health Companies Inc
- Baxter Biopharma Solutions
- Bayer AG
- BDR Pharmaceuticals Internationals Pvt Ltd
- Beijing Institute of Biological Products
- Beijing Minhai Biotechnology Co Ltd
- Bharat Biotech Ltd
- Binnopharm JSC
- Biocad
- BioCell Corp Ltd
- BioCentriq
- Biocon Ltd
- BioConvergence LLC
- Biofabri SL
- Biogen Inc
- Biological E Ltd
- BioNTech SE
- Biotechpharma UAB
- Bryllan LLC
- Cadila Healthcare Ltd
- Cambrex Corp
- Cascade Chemistry
- Catalent Inc
- Celltrion Inc
- Celonic AG
- Cenexi SAS
- Centaur Biopharmaceutical Services Inc
- Chime Biologics Ltd
- CinnaGen Ilac San ve Tic AS
- Cipla Ltd
- Clover Biopharmaceuticals
- CMIC Holdings Co Ltd
- Cobra Biologics Ltd
- CSL Behring Australia Pty Ltd
- Curia Inc
- Daiichi Sankyo Biotech Co Ltd
- Dalton Pharma Services
- Delpharm SAS
- Dr. Reddy's Laboratories Ltd
- Drugmex SAPI de CV
- Dyadic International Inc
- Eli Lilly and Co
- Emergent BioSolutions Inc
- Esteve Huayi Pharmaceutical Co Ltd
- EUSA Pharma
- Exelead Inc
- Exothera SA
- Fareva SA
- Flamma SpA
- Fujifilm Corp
- GALENpharma GmbH
- Gamaleya Federal Research Center of Epidemiology and Microbiology
- GC Pharma
- Genentech USA Inc
- Generium
- Genscript Biotech Corp
- Gilead Sciences Inc
- Gland Pharma Ltd
- GlaxoSmithKline Inc
- Goodwin Biotechnology Inc
- Grand River Aseptic Manufacturing Inc
- Haffkine Bio-Pharmaceutical Corp Ltd
- Hainan Visum Pharmaceutical Co Ltd
- Halix BV
- Hankook Korus Pharm Co Ltd
- Hester Biosciences Ltd
- Hetero Drugs Ltd
- Hikma Pharmaceuticals Plc
- Hoffmann-La Roche Ltd
- Hualan Biological Engineering Inc
- Humanigen
- iBio Inc
- IDT Biologika GmbH
- Indian Immunologicals Ltd
- Institute of Medical Biology Chinese Academy of Medical Sciences
- Institute of Virology Vaccines and Sera Torlak
- Insud Pharma
- IriSys LLC
- ISU ABXIS Co Ltd
- Janssen Biotech Inc
- JCR Pharmaceuticals Co Ltd
- Jubilant HollisterStier LLC
- Jubilant Pharmova Ltd
- Julphar Saudi Arabia LLC
- Kaneka Corp
- Kaneka Eurogentec SA
- Kern Pharma SL
- KM Biologics Co Ltd
- Laboratorio Reig Jofre SA
- Laboratorios de Biologicos y Reactivos de Mexico SA de CV
- Laboratorios Farmaceuticos Rovi SA
- Laboratorios Richmond SACIF
- LakePharma Inc
- LFB Biomanufacturing
- List Biological Laboratories Inc
- Lonza Group Ltd
- Mabxience Holding SL
- Mankind Pharma Ltd
- Medicago
- Merck
- Merck & Co Inc
- Mibe GmbH Arzneimittel
- MilliporeSigma
- Mithra Pharmaceuticals SA
- Moderna Inc
- Morepen Laboratories Ltd
- National Resilience Inc
- National Resilience Inc (including subsidiaries Ology Bioservices Inc, Therapure Biopharma Inc)
- Nephron Pharmaceuticals Corp
- NeuroRx
- Nipro Pharma Corp
- Northern RNA Inc
- Novartis AG
- Novartis Farma SpA
- Novasep Holding SAS
- Novavax
- Oakwood Laboratories LLC
- Oxford BioMedica Plc
- Panacea Biotec Ltd
- Par Sterile Products LLC
- Patheon NV (Thermo Fisher Scientific)
- PCI Pharma Services
- Pfizer Inc
- PharmaMar
- Pharmaniaga Berhad
- Pharmasyntez
- Pharmstandard
- Polymun Scientific Immunbiologische Forschung GmbH
- PolyPeptide Group AG
- Polyvac
- PT Bio Farma
- Quotient Sciences Ltd
- Recipharm AB
- RedHill Biopharma
- Regeneron Pharmaceuticals Inc
- Rentschler Biopharma SE
- Rhein-Minapharm Biogenetics SAE
- Richter-Helm BioLogics GmbH & Co KG
- Ridgeback
- R-Pharm
- Saidal
- Samsung Biologics Co Ltd
- Sanofi
- Saptagir Laboratories Pvt Ltd
- Sciarra Laboratories Inc
- Serum Institute of India Pvt Ltd
- SGS Life Science Services
- Shenzhen Yuanxing Gene Technology Co Ltd
- Shilpa Medicare Ltd
- Siegfried Holding AG
- Sinovac Biotech Ltd
- SK Bioscience Co Ltd
- Sorrento Therapeutics Inc
- Sothema
- Sovereign Pharma Pvt Ltd
- Spera Nexus Inc
- Spera Pharma Inc
- STC Biologics Inc
- Stelis Biopharma Pvt Ltd
- Sterling Pharma Solutions Ltd
- Strides Pharma Science Ltd
- Summit Biosciences Inc
- Supriya Lifescience Ltd
- Symbiosis Pharmaceutical Services Ltd
- Synairgen
- Sypharma Pty Ltd
- The Biovac Institute
- The State Research Center of Virology and Biotechnology VECTOR
- TopRidge Pharma Ltd
- Turk Ilac ve Serum Sanayi AS
- Uniao Quimica Farmaceutica Nacional SA
- Unigen Co Ltd
- UPM Pharmaceuticals Inc
- Vabiotech
- Vacsera
- Valneva
- Vaxart
- Vectura Group Plc
- Vetter Pharma-Fertigung GmbH & Co KG
- VGXI Inc
- Vibalogics GmbH
- Vigene Biosciences Inc
- Virchow Biotech Pvt Ltd
- Wacker Chemie AG
- Waisman Biomanufacturing
- WuXi Biologics
- Zydus Healthcare Ltd
